Tenaya Therapeutics Inc.

NASDAQ: TNYA · Real-Time Price · USD
1.16
0.21 (22.51%)
At close: Aug 15, 2025, 3:59 PM
1.17
0.81%
After-hours: Aug 15, 2025, 07:56 PM EDT

Tenaya Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-23.28M -26.86M -23.84M -25.63M -29.43M -32.23M -29.93M -29.14M -33.27M -31.74M -33.52M -30.7M -28.4M -31.06M -26.15M -18.26M -15.21M -13.1M
Depreciation & Amortization
2.38M 2.66M 2.09M 2.1M 2.12M 2.15M 2.99M 2.18M 2.19M 2.13M 2.12M 2.09M 1.3M 966K 791K 746K 735K 689K
Stock-Based Compensation
3.64M 3.73M 3.76M 3.91M 4.61M 4.22M 3.95M 4.01M 3.83M 3.51M 3.19M 3.17M 3.01M 2.09M 1.05M 968K 502K 432K
Other Working Capital
3.06M -3.06M -335K 4.3M 493K -4.91M -366K 1.53M -418K -3.11M 1.52M -2.98M -1.6M 544K 1.38M -1.58M 946K -4.6M
Other Non-Cash Items
-1.78M 795K 636K -5.79M 12.31M 8.09M 11.97M 848K 829K 239K 543K 537K 601K 475K 321K 309K 263K 171K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -10.23M -315K -489K n/a n/a n/a n/a n/a 182K 10K n/a n/a
Change in Working Capital
3.44M -3.44M -1.04M 5.58M -1.94M -3.64M -671K -1.22M 683K -4.44M 4.99M -2.66M -1.94M -1.24M 7.46M -428K 1.69M -3.98M
Operating Cash Flow
-15.61M -23.11M -18.39M -19.84M -23.62M -28.66M -21.92M -23.64M -26.22M -30.29M -22.68M -27.56M -25.43M -28.76M -16.35M -16.66M -12.02M -15.79M
Capital Expenditures
-142K -383K -204K -184K -73K -564K -394K -8K -208K -629K -795K -4.06M -7.18M -8.6M -12.55M -5.01M -3.24M -4.32M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -35.1K -37.39K n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a -2.01M -50.61M -10.81M -23.64M -15.65M n/a -15.2M -25.8M -31.74M -43.6M -21.96M -43.17M -50.03M -163.42M n/a n/a
Sales Maturities Of Investments
25.13M 22.68M 16.32M 20.68M 32.49M 19.72M 1.14M 30.5M 40.48M 34.5M 38.5M 78.7M 59.35M 68.2M n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 12K 4K 1K -18K -4K 9K -12K 8K 35.1K 37.39K 25.03K -50.03K -163.42M n/a n/a
Investing Cash Flow
24.99M 22.3M 14.1M -30.1M 21.61M -4.49M -14.92M 30.49M 25.09M 8.06M 5.97M 31.03M 30.21M 16.43M -62.58M -168.43M -3.24M -4.32M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -21K -3K -10K n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
982K n/a 377K 31K 570K 9K 371K n/a 311K -501K 99K 6K 260K 15K -21K 1.67M -1.3M 29K
Financial Cash Flow
-476K 50.26M 377K 31K 570K 46.77M 371K n/a 4.18M -501K 77.49M 6K 260K 15K -21K 190.27M -1.3M 20.02M
Net Cash Flow
8.9M 49.45M -3.91M -49.9M -1.17M 13.62M -36.47M 6.85M 3.04M -22.73M 60.78M 3.48M 5.04M -12.31M -78.95M 5.19M -16.55M -97K
Free Cash Flow
-15.76M -23.5M -18.59M -20.02M -23.69M -29.22M -22.32M -23.65M -26.43M -30.92M -23.48M -31.62M -32.61M -37.35M -28.9M -21.66M -15.26M -20.11M